Charles Swanton
Affiliations: | The Francis Crick Institute, London, England, United Kingdom |
Google:
"Charles Swanton"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Swanton C, Bernard E, Abbosh C, et al. (2024) Embracing cancer complexity: Hallmarks of systemic disease. Cell. 187: 1589-1616 |
| Usaite I, Biswas D, Dijkstra K, et al. (2023) Quantifying the impact of immunotherapy on RNA dynamics in cancer. Journal For Immunotherapy of Cancer. 11 |
| Attig J, Pape J, Doglio L, et al. (2023) Human endogenous retrovirus onco-exaptation counters cancer cell senescence through Calbindin. The Journal of Clinical Investigation |
| Weeden CE, Hill W, Lim EL, et al. (2023) Impact of risk factors on early cancer evolution. Cell. 186: 1541-1563 |
| Frankell AM, Dietzen M, Al Bakir M, et al. (2023) The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature |
| Martínez-Ruiz C, Black JRM, Puttick C, et al. (2023) Genomic-transcriptomic evolution in lung cancer and metastasis. Nature |
| Venkatesan S, Angelova M, Bartkova J, et al. (2022) APOBEC3 as a driver of genetic intratumor heterogeneity. Molecular & Cellular Oncology. 10: 2014734 |
| Martins FC, Couturier DL, de Santiago I, et al. (2022) Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer. Nature Communications. 13: 6360 |
| Lange JT, Rose JC, Chen CY, et al. (2022) The evolutionary dynamics of extrachromosomal DNA in human cancers. Nature Genetics |
| Pich O, Bailey C, Watkins TBK, et al. (2022) The translational challenges of precision oncology. Cancer Cell. 40: 458-478 |